Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study

被引：0
|
作者：
Elizabeth Poplin
John Roberts
Marybeth Tombs
Steven Grant
Eric Rubin
机构：
[1] Virginia Commonwealth University,The Massey Cancer Center of the Medical College of Virginia
[2] University of Medicine and Dentistry of New Jersey,The Cancer Institute of New Jersey
来源：
Investigational New Drugs | 1999年 / 17卷
关键词：
gemcitabine; fluorouracil; Phase I study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gemcitabine is a chemotherapy agent with efficacy in the treatment of lung, pancreas, bladder and breast cancer. It inhibits DNA synthesis by interfering with cytidine triphosphate production and also inhibits the activity of ribonucleotide reductase. Gemcitabine may potentiate fluorouracil's inhibition of thymidylate synthase. This inhibition would be expected to be sequence dependent, occurring only if gemcitabine were administered following fluorouracil (5FU).
引用
收藏
页码：57 / 61
页数：4
相关论文
共 50 条
  • [31] A PHASE-I TRIAL OF PROTRACTED 5-FLUOROURACIL INFUSION AND ORAL CALCIUM LEUCOVORIN
    HANSEN, RM
    BEATTY, PA
    QUEBBEMAN, EJ
    ANDERSON, T
    CANCER INVESTIGATION, 1993, 11 (03) : 247 - 251
  • [32] Phase I Trial of Sorafenib in Combination With 5-Fluorouracil/Leucovorin in Advanced Solid Tumors
    Shacham-Shmueli, Einat
    Geva, Ravit
    Figer, Arie
    Bulocinic, Sarah
    Nalbandyan, Karen
    Shpigel, Shulim
    Atsmon, Jacob
    Brendel, Erich
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (05): : 656 - 669
  • [33] HIGH-DOSE INTRAVENOUS ZIDOVUDINE WITH 5-FLUOROURACIL AND LEUCOVORIN - A PHASE I TRIAL
    POSNER, MR
    DARNOWSKI, JW
    WEITBERG, AB
    DUDLEY, MN
    CORVESE, D
    CUMMINGS, FJ
    CLARK, J
    MURRAY, C
    CLENDENNIN, N
    BIGLEY, J
    CALABRESI, P
    CANCER, 1992, 70 (12) : 2929 - 2934
  • [34] LEUCOVORIN INCREASES THE TOXICITY OF 5-FLUOROURACIL - PHASE-I CLINICAL PHARMACOLOGICAL TRIALS
    BRUCKNER, HW
    STORCH, JA
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 192 - 192
  • [35] DUAL MODULATION OF 5-FLUOROURACIL USING LEUCOVORIN AND HYDROXYUREA - A PHASE-I TRIAL
    LOKICH, J
    ANDERSON, N
    BERN, M
    COCO, F
    ZIPOLI, T
    MOORE, C
    GONSALVES, L
    CANCER, 1991, 68 (04) : 744 - 746
  • [36] Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor
    Cascino, TL
    Veeder, MH
    Buckner, JC
    OFallon, JR
    Wiesenfeld, M
    Levitt, R
    Goldberg, RM
    Kuross, SA
    Morton, RF
    Scheithauer, BW
    JOURNAL OF NEURO-ONCOLOGY, 1996, 30 (03) : 243 - 246
  • [37] Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
    Shiah, HS
    Cheng, AL
    Hsu, C
    Hsu, CH
    Liu, TW
    Chang, JY
    Jan, CM
    Chao, Y
    Yu, WL
    Chuang, TR
    Whang-Peng, J
    Chen, LT
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (03) : 531 - 536
  • [38] Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer
    Chayahara, Naoko
    Tamura, Takao
    Yamamori, Motohiro
    Kadowaki, Yuko
    Okuno, Tatsuya
    Miki, Ikuya
    Tsuda, Masahiro
    Nishisaki, Hogara
    Maeda, Tetsuo
    Inoue, Yoshifumi
    Okumura, Katsuhiko
    Azuma, Takeshi
    Kasuga, Masato
    Sakaeda, Toshiyuki
    Hirai, Midori
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 56 - 60
  • [39] PHASE I STUDY OF FTORAFUR, AN ANALOG OF 5-FLUOROURACIL
    SMART, CR
    TOWNSEND, LB
    RUSHO, WJ
    EYRE, HJ
    QUAGLIANA, JM
    WILSON, ML
    EDWARDS, CB
    MANNING, SJ
    CANCER, 1975, 36 (01) : 103 - 106
  • [40] Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction
    Fleming, GF
    Schilsky, RL
    Schumm, LP
    Meyerson, A
    Hong, AM
    Vogelzang, NJ
    Ratain, MJ
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1142 - 1147
12345